{"transactions":[{"id":3392930,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":104428,"kind":"organization","name":"Bill & Melinda Gates Foundation","position":1,"cik":"0001663801","reported_name":"Bill & Melinda Gates Foundation","relationship":{"ten_percent_owner":true}}],"security":"Series B convertible preferred stock","published_at":"2019-10-16T20:31:56.000Z","date":"2019-10-16","kind":"exercise","acquired":false,"shares":555555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon closing of the Issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration.  There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration.  There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration.  There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":555555},"source":{"system":"sec-edgar","filing":"0000898432-19-001252","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000089843219001252/form4.xml","form_type":"4"}},{"id":3392929,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":104428,"kind":"organization","name":"Bill & Melinda Gates Foundation","position":1,"cik":"0001663801","reported_name":"Bill & Melinda Gates Foundation","relationship":{"ten_percent_owner":true}}],"security":"Series A-1 convertible preferred stock","published_at":"2019-10-16T20:31:56.000Z","date":"2019-10-16","kind":"exercise","acquired":false,"shares":2222222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon closing of the Issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration.  There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration.  There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon closing of the Issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration.  There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2222222},"source":{"system":"sec-edgar","filing":"0000898432-19-001252","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000089843219001252/form4.xml","form_type":"4"}},{"id":3392928,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":104428,"kind":"organization","name":"Bill & Melinda Gates Foundation","position":1,"cik":"0001663801","reported_name":"Bill & Melinda Gates Foundation","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2019-10-16T20:31:56.000Z","date":"2019-10-16","kind":"exercise","acquired":true,"shares":2777777,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Upon closing of the Issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration.  There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon closing of the Issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration.  There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock."}],"balance_after":2777777,"source":{"system":"sec-edgar","filing":"0000898432-19-001252","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000089843219001252/form4.xml","form_type":"4"}},{"id":3479797,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":104428,"kind":"organization","name":"Bill & Melinda Gates Foundation","position":1,"cik":"0001663801","reported_name":"Bill & Melinda Gates Foundation","relationship":{"ten_percent_owner":true}}],"security":"Series A Preferred Stock","published_at":"2019-06-24T17:23:28.000Z","date":"2019-06-24","kind":"exercise","acquired":false,"shares":1396644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon closing of the issuer's initial public offering, the Series A Preferred Stock converted automatically into Class A Common Stock on a 1-for-1 basis without payment of further consideration.  There was no expiration date for the Series A Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon closing of the issuer's initial public offering, the Series A Preferred Stock converted automatically into Class A Common Stock on a 1-for-1 basis without payment of further consideration.  There was no expiration date for the Series A Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon closing of the issuer's initial public offering, the Series A Preferred Stock converted automatically into Class A Common Stock on a 1-for-1 basis without payment of further consideration.  There was no expiration date for the Series A Preferred Stock."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1396644},"source":{"system":"sec-edgar","filing":"0000898432-19-000930","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1532346/000089843219000930/form4.xml","form_type":"4"}},{"id":3479796,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":104428,"kind":"organization","name":"Bill & Melinda Gates Foundation","position":1,"cik":"0001663801","reported_name":"Bill & Melinda Gates Foundation","relationship":{"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2019-06-24T17:23:28.000Z","date":"2019-06-24","kind":"exercise","acquired":true,"shares":1396644,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Upon closing of the issuer's initial public offering, the Series A Preferred Stock converted automatically into Class A Common Stock on a 1-for-1 basis without payment of further consideration.  There was no expiration date for the Series A Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon closing of the issuer's initial public offering, the Series A Preferred Stock converted automatically into Class A Common Stock on a 1-for-1 basis without payment of further consideration.  There was no expiration date for the Series A Preferred Stock."}],"balance_after":1396644,"source":{"system":"sec-edgar","filing":"0000898432-19-000930","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1532346/000089843219000930/form4.xml","form_type":"4"}},{"id":3856605,"issuer":{"id":145051,"kind":"organization","name":"Liquidia Technologies Inc","symbol":"LQDA"},"owners":[{"id":104428,"kind":"organization","name":"Bill & Melinda Gates Foundation","position":1,"cik":"0001663801","reported_name":"Bill & Melinda Gates Foundation","relationship":{"ten_percent_owner":true}}],"security":"Series C-1 Preferred Stock","published_at":"2018-08-01T17:26:27.000Z","date":"2018-07-30","kind":"exercise","acquired":false,"shares":11286115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"All shares of Series C-1 Preferred Stock, par value $0.001 per share, had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.0706-for-1 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All shares of Series C-1 Preferred Stock, par value $0.001 per share, had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.0706-for-1 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"All shares of Series C-1 Preferred Stock, par value $0.001 per share, had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.0706-for-1 basis immediately prior to the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":797073},"source":{"system":"sec-edgar","filing":"0000898432-18-000882","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1330436/000089843218000882/form4.xml","form_type":"4"}},{"id":3856604,"issuer":{"id":145051,"kind":"organization","name":"Liquidia Technologies Inc","symbol":"LQDA"},"owners":[{"id":104428,"kind":"organization","name":"Bill & Melinda Gates Foundation","position":1,"cik":"0001663801","reported_name":"Bill & Melinda Gates Foundation","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2018-08-01T17:26:27.000Z","date":"2018-07-30","kind":"exercise","acquired":true,"shares":797073,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All shares of Series C-1 Preferred Stock, par value $0.001 per share, had no expiration date and automatically converted into the Issuer's common stock on approximately a 0.0706-for-1 basis immediately prior to the closing of the Issuer's initial public offering."}],"balance_after":797073,"source":{"system":"sec-edgar","filing":"0000898432-18-000882","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1330436/000089843218000882/form4.xml","form_type":"4"}},{"id":4155941,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":104428,"kind":"organization","name":"Bill & Melinda Gates Foundation","position":1,"cik":"0001663801","reported_name":"Bill & Melinda Gates Foundation","relationship":{"ten_percent_owner":true}}],"security":"Series D Convertible Preferred Stock","published_at":"2017-11-21T00:09:33.000Z","date":"2017-11-20","kind":"exercise","acquired":false,"shares":2464799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon closing of the issuer's initial public offering, the Series D Convertible Preferred Stock converted automatically into Common Stock on a 0.29300-for-1 basis without payment of further consideration.  There was no expiration date for the Series D Convertible Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon closing of the issuer's initial public offering, the Series D Convertible Preferred Stock converted automatically into Common Stock on a 0.29300-for-1 basis without payment of further consideration.  There was no expiration date for the Series D Convertible Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon closing of the issuer's initial public offering, the Series D Convertible Preferred Stock converted automatically into Common Stock on a 0.29300-for-1 basis without payment of further consideration.  There was no expiration date for the Series D Convertible Preferred Stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":722179},"source":{"system":"sec-edgar","filing":"0000898432-17-001103","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000089843217001103/form4.xml","form_type":"4"}},{"id":4155940,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":104428,"kind":"organization","name":"Bill & Melinda Gates Foundation","position":1,"cik":"0001663801","reported_name":"Bill & Melinda Gates Foundation","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2017-11-21T00:09:33.000Z","date":"2017-11-20","kind":"exercise","acquired":true,"shares":722179,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Upon closing of the issuer's initial public offering, the Series D Convertible Preferred Stock converted automatically into Common Stock on a 0.29300-for-1 basis without payment of further consideration.  There was no expiration date for the Series D Convertible Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon closing of the issuer's initial public offering, the Series D Convertible Preferred Stock converted automatically into Common Stock on a 0.29300-for-1 basis without payment of further consideration.  There was no expiration date for the Series D Convertible Preferred Stock."}],"balance_after":722179,"source":{"system":"sec-edgar","filing":"0000898432-17-001103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000089843217001103/form4.xml","form_type":"4"}}]}